INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 9 Apr · 15:33 IST

Ind-Swift Laboratories Limited has informed the Exchange about Clarification on Spurt in Volume

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹143.48
prior close
₹144.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.6+0.9+1.0-3.5+0.9+1.4-7.9-2.1-0.7-0.3-3.8+13.5+72.1
Up moveDown movePending
AI summary

NSE sought clarification from Ind-Swift Laboratories regarding a sudden surge in trading volume on 8th April 2026. The company responded on 9th April, stating it is not aware of the reason for the volume spurt and has always made timely disclosures under SEBI regulations. The company attributed the movement to market-driven factors. This follows an earlier disclosure (7th April 2026) informing exchanges about an Arbitration Award in a dispute with PI Industries Limited. The Arbitral Tribunal rejected both all claims by PI Industries (the claimant) and all counterclaims by Ind-Swift (the respondent). The proceedings are now concluded with NIL financial impact on the company. The company confirmed it has complied with Regulation 30 of SEBI Listing Regulations and is not aware of any undisclosed material information that could explain the price/volume movement.

Likely market impact

The nil financial impact arbitration outcome is neutral for the company; however, the stock experienced significant volume movement likely driven by speculation around the arbitration ruling being positive news. The exchange has been formally notified with no undisclosed material issues identified.